Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991009127) BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/009127 International Application No.: PCT/US1990/007288
Publication Date: 27.06.1991 International Filing Date: 18.12.1990
Chapter 2 Demand Filed: 15.07.1991
IPC:
A61K 38/00 (2006.01) ,C07K 14/05 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
05
Epstein-Barr virus
Applicants:
SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road Kenilworth, NJ 07033, US (AllExceptUS)
MOORE, Kevin, W. [US/US]; US (UsOnly)
KASTELEIN, Robert, A. [NL/US]; US (UsOnly)
Inventors:
MOORE, Kevin, W.; US
KASTELEIN, Robert, A.; US
Agent:
BLASDALE, John, H., C. ; Schering-Plough Corporation One Giralda Farms Madison, NJ 07940-1000, US
Priority Data:
453,93120.12.1989US
Title (EN) BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)
(FR) PROTEINES BCRF1 EN TANT QU'INHIBITEURS D'INTERFERON-$g(g)
Abstract:
(EN) BCRF1 proteins, and expression vectors for producing them, are provided for treating conditions associated with excessive production of IFN-$g(g). Compositions of the invention containing BCRF1 proteins are useful in treating a variety of disorders, including allergy, psoriasis, tissue rejection, and MHC-linked autoimmune diseases.
(FR) On décrit des protéines BCFR1, et les vecteurs d'expression permettant de les produire, utiles dans le traitement des conditions associées à la production excessive d'IFN-$g(g). Les compositions de l'invention contenant des protéines BCRF1 sont utiles dans le traitement d'un ensemble de troubles, y compris les allergies, le psoriasis, le rejet de tissus ainsi que les maladies autoimmunes liées au complexe d'histocompatibilité majeur (MHC).
Designated States: AU, BB, BG, BR, CA, FI, HU, JP, KP, KR, LK, MC, MG, MW, NO, RO, SD, SU, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CM, GA, ML, MR, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
FI922770NO19922456MXPA/a/1992/003409IL96715EP0506836JPH05503846
CA2071907KR1019960015199*AU1991070636AU1994078996ID001.699